Login / Signup

Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study.

Line MelgaardMartin JensenThure Filskov OvervadTorben B LarsenGregory Yoke Hong LipPeter B Nielsen
Published in: International journal of clinical practice (2020)
When using data reflecting contemporary clinical practice, we observed markedly different risks of thromboembolism and bleeding in EHRA Type 1 and Type 2 VHD. Additionally, we observed a potential underuse of oral anticoagulation within the subgroups of AF patients with EHRA Type 1 and Type 2 VHD, underlining need for further attention on this patient group.
Keyphrases
  • atrial fibrillation
  • clinical practice
  • cross sectional
  • human health
  • case report
  • type diabetes
  • working memory
  • risk assessment
  • aortic valve
  • electronic health record
  • big data
  • metabolic syndrome